STE vs TACT · P/E 25, rev $5.46B vs rev $10.2M
STERIS plc (STE) versus TransAct Technologies Incorporated (TACT) — a side-by-side from cached financials, not a winner call.
STERIS plc (STE) is a medical devices company listed on NYSE.
TransAct Technologies Incorporated (TACT) is a computer hardware company listed on US.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Latest reported TACT revenue for 2024-12-31 was $10.2M. Net income was -$8.0M. Revenue was down 5.9% from 2024-09-30 to 2024-12-31. TACT currently screens at market cap $49.3M.
STE currently screens at market cap $19.43B and trailing P/E 25.1. TACT currently screens at market cap $49.3M.
Not investment advice. Open the STE and TACT stock pages for the full models.
Not investment advice.